fbpx
QQQ
-1.25
343.51
-0.37%
DIA
-2.67
346.08
-0.78%
SPY
-2.22
426.70
-0.52%
TLT
-0.12
141.17
-0.09%
GLD
-2.96
177.01
-1.7%

Why Novan Shares Are Surging Today

June 11, 2021 9:16 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Novan Inc (NASDAQ:NOVN) shares are trading higher by 59% at $14.37 Friday morning after the company reported the B-SIMPLE4 pivotal Phase 3 trial of SB206 achieved statistical significance for the primary endpoint and no serious adverse events were reported.

See Also: A Technical Look At Novan's Stock Amid 80% Spike

Novan is a clinical-stage biotechnology company that provides nitric oxide-based therapies to treat dermatological and oncovirus-mediated diseases.

Novan's clinical-stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete's foot and fungal nail infections; and SB414, a topical cream-based gel product candidate for the treatment of inflammatory skin diseases.

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to our YouTube channel.


Related Articles

A Technical Look At Novan's Stock Amid 80% Spike

Novan Inc. (NASDAQ: NOVN) shares are trading higher Friday after the company reported that B-SIMPLE4 pivotal Phase 3 trial of SB206 achieved significance for the primary endpoint with no adverse events. read more

Novan CEO Talks About The Company's Future: 'Our Focus Is Put On SB204'